Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Tomer Kariv currently holds 10,000 shares of Keros Therapeutics, Inc. (KROS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Tomer Kariv has been a net buyer of KROS stock. They have purchased $27.5M and sold $0 worth of shares.
Tomer Kariv's most recent insider trade was on May 30, 2024, when they sold 10,000 shares at $0.00 per share.
Tomer Kariv serves as Executive at Keros Therapeutics, Inc. (KROS). They have executed 73 insider transactions totaling $27.5M over their tenure at the company.
Tomer Kariv holds the position of Executive at Keros Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 13 years and currently hold a stake valued at $0.
Tomer Kariv has shown a buying trading pattern, with $27.5M in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Tomer Kariv was on May 13, 2021, when they purchased $3.6M worth of ELOX shares. This transaction involved 2,630,487 shares at $1.35 per share.
Tomer Kariv currently owns 10,000 shares of Keros Therapeutics, Inc. (KROS), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Tomer Kariv's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Tomer Kariv has 73 Form 4 filings on record as an insider at Keros Therapeutics, Inc..
Set alerts for Tomer Kariv and 40,000+ other insiders.